Cargando…
Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives
Pancreatic cancer is the most common lethal malignancy, with little improvement in patient outcomes over the decades. The development of early detection methods and effective therapeutic strategies are needed to improve the prognosis of patients with this disease. Recent advances in cancer genomics...
Autores principales: | Miyabayashi, Koji, Nakagawa, Hayato, Koike, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260689/ https://www.ncbi.nlm.nih.gov/pubmed/34249730 http://dx.doi.org/10.3389/fonc.2021.682872 |
Ejemplares similares
-
Precision Medicine Targeting FGFR2 Genomic Alterations in Advanced Cholangiocarcinoma: Current State and Future Perspectives
por: Zugman, Miguel, et al.
Publicado: (2022) -
Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
por: Regel, Ivonne, et al.
Publicado: (2020) -
S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives
por: Wu, Yu, et al.
Publicado: (2021) -
Molecular Profiling–Based Precision Medicine in Cancer: A Review of Current Evidence and Challenges
por: Zhang, Qi, et al.
Publicado: (2020) -
Precision Medicine in Diabetes, Current Research and Future Perspectives
por: Franceschi, Roberto
Publicado: (2022)